Aug 2026· iScience· Vol 29, pp. 116517· 0 citations· 44 references
Medicine
TL;DR
It is found that the specific role of macrophages in disease progression is context-dependent and Activated HLA-DR+ inflammatory macrophages directly in contact with cancer cells at the tumor boundary are associated with responsiveness to therapies and improved patient survival.
Abstract
Summary Despite advances in treatment approaches, the mean survival for patients with brain metastases remains poor. The incidence of brain metastases continues to rise, and there remains a need to identify novel therapeutics targeting mechanisms critical for brain metastasis. We employed a multi-omic approach, including single nuclei and spatially resolved transcriptomic profiling across 23 brain metastatic samples, with the representation of lung, breast, and melanoma metastases, to identify tumor-microenvironment interactions associated with survival outcomes in brain metastasis. We found that the specific role of macrophages in disease progression is context-dependent. Activated HLA-DR+ inflammatory macrophages directly in contact with cancer cells at the tumor boundary are associated with responsiveness to therapies and improved patient survival. Conversely, reprogrammed macrophages expressing extracellular matrix proteins and TGFβ1 are associated with poor survival. These findings identify spatially distinct tumor cell-macrophage interactions associated with survival outcomes in patients with brain metastases and represent targets for immunotherapy strategies.
A unique single-cell spatial framework on metastatic breast cancer development and progression is presented, in a highly complex systemic treatment landscape.
Z. Dauyey, A. Velds, R. Gobits et al.· medRxiv· 0 citations
Metastatic breast cancer remains incurable, underscoring the need for novel therapeutic strategies. Epidemiological and preclinical evidence suggests statins suppress metastatic outgrowth, however the underlying mechanisms remain unclear. We employed high-resolution spatial transcriptomics (ST) to explore the cellular...
Neha Atale, Jie Chen, Brian R. Isett et al.· Neoplasia· 0 citations
It is argued that spatial technologies do not replace existing therapeutic pipelines but address a critical blind spot: the spatial dimension that bulk measurements cannot see.
Juan Yuan, Yong Liu· Frontiers in Immunology· 0 citations
PURPOSE
No curative options are available for medulloblastoma (MB) in the relapse setting. The tumor microenvironment (TME) influences progression and therapy response, presenting a promising target for therapeutic advances. Prior single-cell analyses have characterized the cellular components of the TME but lack spati...
F. Chien, Marina E. Michaud, Mojtaba Bakhtiari et al.· JCO Precision Oncology· 0 citations
Glioblastoma, IDH-wildtype, CNS WHO grade 4 (GBM) is the most aggressive primary malignant brain tumor in adults, with a median overall survival of approximately 15 months despite maximal surgical resection, radiotherapy, and chemotherapy with temozolomide. This therapeutic resistance is increasingly attributed to the...
Jia-Na Lei, Mei Lao, Zhuo-Na Ni et al.· Frontiers in Immunology· 0 citations
How spatially structured cellular ecosystems, rather than individual cell types, determine therapeutic response and resistance in lung cancer is organized around a single question - and observations that are reproducible across independent cohorts and platforms are explicitly separate from those that remain confined to...
C. Braicu, R. Pîrlog, A. Nutu et al.· Biochimica et biophysica act...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.